Skip to content
Home/Companies/Healthcare/RoukenBio
RO

RoukenBio

Healthcare·UK·Active·3yr hold

RoukenBio is a healthcare company, headquartered in United Kingdom.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns RoukenBio?

RoukenBio is currently owned by NorthEdge Capital through NorthEdge Fund III (2020 vintage), since 2023.

Hand-verified · updated 2026-04-21

NorthEdge Capital
Investor
NorthEdge Capital
NorthEdge Fund III · 2020 · Buyout

Key facts

HQUnited Kingdom
SectorHealthcare

More from NorthEdge Fund III

Other portfolio companies in the same fund.

Oak Engage
Active
SaaSUK· 2025
Contollo
Active
Business ServicesUK· 2024
Latus Group
Active
HealthcareUK· 2024
PebblePad
Active
EdTechUK· 2024
Torbay Pharmaceuticals
Active
PharmaUK· 2023
Friend MTS
Active
CybersecurityUK· 2022

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings